TE_129

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MLT1E1A
TE superfamily MaLR
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 5.52
Counts of samples TCGA_tumor:92; TCGA_normal:2; GTEx:16
TSS chr1(-):14737855



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_129.1 - Intergenic Non-coding Non-coding chr1(-):14735885,14735905,14737577,14737856
teRNA_129.2 - Intergenic Non-coding Non-coding chr1(-):14726590,14726610,14735671,14735905,14737577,14737856
teRNA_129.3 - Intergenic Non-coding Non-coding chr1(-):14733568,14733588,14735671,14735905,14737577,14737856
teRNA_129.4 - Intergenic Non-coding Non-coding chr1(-):14726590,14726610,14727823,14727927,14735671,14735905,14737577,14737856
teRNA_129.5 - Intergenic Non-coding Non-coding chr1(-):14733681,14733701,14735671,14735905,14737577,14737856
teRNA_129.6 - Intergenic Non-coding Non-coding chr1(-):14736679,14736699,14737577,14737856


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).